EMD Serono notifies FDA of a Shortage of tesamorelin
EMD Serono notifies FDA of a Shortage of tesamorelin
Sep 18, 2013
Supporting Materials:
Theratechnologies Inc. (TSX: TH) announced today that EMD Serono voluntarily notified the United States Food and Drug Administration (FDA) about an upcoming shortage of tesamorelin in the United States.